SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-001850
Filing Date
2024-01-04
Accepted
2024-01-04 06:31:00
Documents
14
Period of Report
2024-01-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d553940d8k.htm   iXBRL 8-K 31103
2 EX-99.1 d553940dex99.htm EX-99 39133
6 GRAPHIC g553940g0103100705584.jpg GRAPHIC 3587
  Complete submission text file 0001193125-24-001850.txt   210520

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA zyme-20240104.xsd EX-101.SCH 2855
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20240104_lab.xml EX-101.LAB 17993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20240104_pre.xml EX-101.PRE 11264
8 EXTRACTED XBRL INSTANCE DOCUMENT d553940d8k_htm.xml XML 3343
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41535 | Film No.: 24509721
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)